Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Vauthier

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Pharmaceutical Research|May 23, 2006
Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharideIsabelle Bertholon, Christine Vauthier, Denis Labarre
Pharmaceutical Research|April 28, 2018
Assessment of Complement Activation by Nanoparticles: Development of a SPR Based Method and Comparison with Current High Throughput MethodsJean-Baptiste Coty, Magali Noiray, Christine Vauthier
Pharmaceutical Research|August 5, 2020
Understanding Nanomedicine Size and Biological Response Dependency: What Is the Relevance of Previous Relationships Established on Only Batch-Mode DLS-Measured Sizes?Elquio Eleamen Oliveira, Maryème Barendji, Christine Vauthier
Biomaterials|November 25, 2010
Protein adsorption and complement activation for di-block copolymer nanoparticlesChristine Vauthier, Bjorn Persson, Peter Lindner, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 14, 2015
Protein-nanoparticle interactions evaluation by immunomethods: Surfactants can disturb quantitative determinationsCristina Fornaguera, Gabriela Calderó, Conxita Solans, et al.
International Journal of Pharmaceutics|October 2, 2021
Nanoparticles facing the gut barrier: Retention or mucosal absorption? Mechanisms and dependency to nanoparticle characteristicsChristelle Zandanel, Gilles Ponchel, Magali Noiray, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 17, 2004
Evidence for restrictive parameters in formulation of insulin-loaded nanocapsulesFabienne Cournarie, Monique Chéron, Madeleine Besnard, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 31, 2006
Properties of polysaccharides grafted on nanoparticles investigated by EPRIsabelle Bertholon, Hubert Hommel, Denis Labarre, et al.
Pharmaceutical Research|December 10, 2003
Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticlesCédric Chauvierre, Denis Labarre, Patrick Couvreur, et al.
International Journal of Pharmaceutics|April 29, 2017
Tuning complement activation and pathway through controlled molecular architecture of dextran chains in nanoparticle coronaJean-Baptiste Coty, Elquio Eleamen Oliveira, Christine Vauthier
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Pharmaceutical Research|May 23, 2006
Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharideIsabelle Bertholon, Christine Vauthier, Denis Labarre
Pharmaceutical Research|April 28, 2018
Assessment of Complement Activation by Nanoparticles: Development of a SPR Based Method and Comparison with Current High Throughput MethodsJean-Baptiste Coty, Magali Noiray, Christine Vauthier
Pharmaceutical Research|August 5, 2020
Understanding Nanomedicine Size and Biological Response Dependency: What Is the Relevance of Previous Relationships Established on Only Batch-Mode DLS-Measured Sizes?Elquio Eleamen Oliveira, Maryème Barendji, Christine Vauthier
Biomaterials|November 25, 2010
Protein adsorption and complement activation for di-block copolymer nanoparticlesChristine Vauthier, Bjorn Persson, Peter Lindner, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 14, 2015
Protein-nanoparticle interactions evaluation by immunomethods: Surfactants can disturb quantitative determinationsCristina Fornaguera, Gabriela Calderó, Conxita Solans, et al.
International Journal of Pharmaceutics|October 2, 2021
Nanoparticles facing the gut barrier: Retention or mucosal absorption? Mechanisms and dependency to nanoparticle characteristicsChristelle Zandanel, Gilles Ponchel, Magali Noiray, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 17, 2004
Evidence for restrictive parameters in formulation of insulin-loaded nanocapsulesFabienne Cournarie, Monique Chéron, Madeleine Besnard, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 31, 2006
Properties of polysaccharides grafted on nanoparticles investigated by EPRIsabelle Bertholon, Hubert Hommel, Denis Labarre, et al.
Pharmaceutical Research|December 10, 2003
Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticlesCédric Chauvierre, Denis Labarre, Patrick Couvreur, et al.
International Journal of Pharmaceutics|April 29, 2017
Tuning complement activation and pathway through controlled molecular architecture of dextran chains in nanoparticle coronaJean-Baptiste Coty, Elquio Eleamen Oliveira, Christine Vauthier
Pageof 7